Literature DB >> 24733629

Isoforms of receptors of fibroblast growth factors.

Siew-Ging Gong1.   

Abstract

The breadth and scope of Fibroblast Growth Factor signaling is immense, with documentation of its role in almost every organism and system studied so far. FGF ligands signal through a family of four distinct tyrosine kinase receptors, the FGF receptors (FGFRs). One contribution to the diversity of function and signaling of FGFs and their receptors arises from the numerous alternative splicing variants that have been documented in the FGFR literature. The present review discusses the types and roles of alternatively spliced variants of the FGFR family members and the significant impact of alternative splicing on the physiological functions of five broad classes of FGFR isoforms. Some characterized known regulatory mechanisms of alternative splicing and future directions in studies of FGFR alternative splicing are also discussed. Presence, absence, and/or the combination of specific exons within each FGFR protein impart upon each individual isoform its unique function and expression pattern during normal function and in diseased states (e.g., in cancers and birth defects). A better understanding of the diversity of FGF signaling in different developmental contexts and diseased states can be achieved through increased knowledge of the presence of specific FGFR isoforms and their impact on downstream signaling and functions. Modern high-throughput techniques afford an opportunity to explore the distribution and function of isoforms of FGFR during development and in diseases.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733629     DOI: 10.1002/jcp.24649

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  23 in total

1.  Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport.

Authors:  W Bruce Sneddon; Giovanni W Ruiz; Luciana I Gallo; Kunhong Xiao; Qiangmin Zhang; Youssef Rbaibi; Ora A Weisz; Gerard L Apodaca; Peter A Friedman
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

2.  Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Fang Xie; Timra Gilson; Elliot J Androphy
Journal:  Virology       Date:  2018-06-06       Impact factor: 3.616

3.  DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas.

Authors:  Kathrin Schramm; Murat Iskar; Britta Statz; Natalie Jäger; Daniel Haag; Mikołaj Słabicki; Stefan M Pfister; Marc Zapatka; Jan Gronych; David T W Jones; Peter Lichter
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

4.  Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2.

Authors:  Stefan Bagheri-Fam; Anthony D Bird; Liang Zhao; Janelle M Ryan; Meiyun Yong; Dagmar Wilhelm; Peter Koopman; Veraragavan P Eswarakumar; Vincent R Harley
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

5.  Polymorphisms of FGFR1 in HBV-related hepatocellular carcinoma.

Authors:  Haiyang Xie; Chunyang Xing; Bajin Wei; Xiao Xu; Liming Wu; Jian Wu; Leiming Chen; Guoqiang Cao; Hai Chen; Xueqin Meng; Shengyong Yin; Lin Zhou; Shusen Zheng
Journal:  Tumour Biol       Date:  2015-06-12

6.  Fibroblast growth factors and pulmonary fibrosis: it's more complex than it sounds.

Authors:  Kevin K Kim; Thomas H Sisson; Jeffrey C Horowitz
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

Review 7.  Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders.

Authors:  Cortney A Turner; Emine Eren-Koçak; Edny G Inui; Stanley J Watson; Huda Akil
Journal:  Semin Cell Dev Biol       Date:  2015-10-23       Impact factor: 7.727

Review 8.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 9.  FGF/FGFR signaling in health and disease.

Authors:  Yangli Xie; Nan Su; Jing Yang; Qiaoyan Tan; Shuo Huang; Min Jin; Zhenhong Ni; Bin Zhang; Dali Zhang; Fengtao Luo; Hangang Chen; Xianding Sun; Jian Q Feng; Huabing Qi; Lin Chen
Journal:  Signal Transduct Target Ther       Date:  2020-09-02

Review 10.  Role of Glycans on Key Cell Surface Receptors That Regulate Cell Proliferation and Cell Death.

Authors:  Yin Gao; Xue Luan; Jacob Melamed; Inka Brockhausen
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.